The patient underwent implantation of a 21mm trifecta valve in 2008.Approximately 7 years later, on (b)(6) 2015, the patient reported with onset of atrial fibrillation and chest pain.On angiography, aortic valve calcification was noted.The patient was scheduled for a tavi valve-in valve on (b)(6) 2015.
|
The results of the investigation are inconclusive since the device was not returned for analysis.Our investigation was limited to the review of the device history record, which showed that each manufacturing and inspection operation was performed and indicated complete in accordance with sjm specifications and procedures.Based on the information received, the cause of the reported incident could not be conclusively determined.
|